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Abstract
Introduction and hypothesis The objectives were to explore
the views of women with recurrent stress incontinence (SUI)
with regard to treatment preferences and the acceptability of
randomisation to a future trial, and to survey the views of UK
specialists on treatment preferences and equipoise regarding
different treatment alternatives.
Methods An online survey of the British Society of
Urogynaecology (BSUG) and British Society of Urological
Surgeons (BAUS) was carried out. Qualitative semi-
structured interviews with a purposive sample of surgeons
and women suffering from recurrent SUI from three UK
centres.
Results Two hundred fifty-six survey replies were received
(176 gynaecology; 80 urology). Comparing the treatments
offered, urogynaecologists were more likely to offer pelvic
floor exercises (p < 0.05), and repeat midurethral tape
(MUT) (p < 0.001). From the Surgical Equipoise Scale
(SES) responses, Bno preference^ was rarely the commonest
response. Marked differences for several options existed;
midurethral tape dominated responses whenever it appeared.
Twenty-one clinicians were interviewed. Treatment prefer-
ences were complex, influenced by a range of factors (reason
for failure, patient comorbidity, investigations, personal expe-
rience, training). A future trial was regarded as important.
Eleven women were interviewed. Most had considered more
than one option, but felt that decision-making was more a
process of elimination rather than a positive process.
Randomisation to a study was regarded as unacceptable by
most.
Conclusions No consensus exists among surgeons about pre-
ferred treatment options for recurrent SUI, and personal expe-
rience and training dominate decision-making. For patients,
choices were usually based on an elimination of options, in-
cluding that of a repeat failed procedure. This contrasts with
surgeons, who mostly preferred a repeat MUT above other
options. Any future comparative study will be challenging.
Keywords Surgery .Stressurinary incontinence .Treatment .
Preference . Qualitative . Randomization
Introduction
Urinary incontinence (UI) in women is a major issue for the
NHS and for society. The prevalence and cost of treatment
pose a significant healthcare burden with an ageing popula-
tion. The Leicestershire MRC Incontinence Study reported
that over a third of community-dwelling women aged 40
and over had significant urinary symptoms, with 12%
experiencing UI weekly [1]. Stress urinary incontinence
(SUI) is a common cause of urinary incontinence and surgery
is a highly effective option. The placement of a midurethral
tape (MUT; retropubic, transobturator route, or single-
incision) to support the urethra is the procedure of choice for
primary surgery among most clinicians.
Data presented at the UK Continence Society, Belfast, 2016, and at the
International Continence Society, Tokyo, 2016
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An MUT is a minimally invasive medical device that can
be inserted under local or general anaesthesia, as day case
surgery. Incontinence cure rates are 60–90%, with a small risk
of bladder injury (5%), voiding difficulty and a low incidence
of long-term tape erosion or extrusion [2]. Systematic reviews
demonstrate retropubic and transobturator tapes to be equally
effective in the short term [3–6]. Hospital Episode statistics for
England for 2014–2015 indicate that continence surgery is a
major driver of caseload and resource cost, with 10,511 con-
tinence procedures being performed (over 9,500 MUTs;
Hospital Episode Statistics for England, 2014–2015) [7].
Despite the effectiveness ofMUT, up to 4 in 10 women suffer
from persistent incontinence after surgery, or develop a recurrent
problem at some point after their primary operation [2]. There is
currently no evidence from randomised controlled trials
(RCTs)—and very little from any other type of study—to guide
clinicians in how to manage recurrent/persistent incontinence,
and no guidance on which is the Bbest^ secondary surgical pro-
cedure surgery. Recent systematic reviews presented limited ev-
idence [8–10]. No randomised controlled trials (RCT) solely
recruited recurrent cases. Subgroup analysis of RCT data was
inconclusive for comparisons between retropubic and
transobturator MUT, or between MUT and colposuspension.
Data from non-randomised studies suggest cure rates of 73–
79% and that retropubic MUT may be more effective than
transoburator [9, 11].
This lack of evidence is a real problem for gynaecologists
and urologists, who are consulted by women suffering from
recurrent or persistent SUI, and who must currently base their
treatment choice on clinical experience and personal prefer-
ence alone. The James Lind Alliance Priority Setting
Partnership for Continence identified the management of
failed primary surgery as one of the ten research priorities in
2010 [12].
Thus, there remains a pressing need for high-quality re-
search addressing this question, but the design of any RCT
in this area is likely to be complex. This paper presents a
mixed methods study of the views and preferences of both
patients and clinicians with regard to the management of failed
primary surgery. Our aim was to identify the issues of greatest
relevance for both groups to inform the planning and design of
future studies comparing options for women requiring further
treatment for recurrent or persistent SUI after primary conti-
nence surgery.
Materials and methods
The study was designed to investigate both patients’ and cli-
nicians’ views and preferences with regard to the acceptabil-
ity, safety and appropriateness of different surgery compari-
sons so that any future clinical trials comparing secondary
surgeries are feasible and effective in terms of recruitment of
participants and willingness of clinicians to allow
randomisation.
Clinician surveys
The aim of the clinician surveys was to assess which surgeries
may be most appropriate for comparison in any future trial in
terms of clinical equipoise and willingness to allow
randomisation.
Members of the British Society of Urogynaecology
(BSUG) and the section of Female, Neurological and
Urodynamic Urology of the British Association of
Urological Surgeons (BAUS) were sent invitations to partici-
pate in an online survey to gather information about which of
the several treatment options for recurrent/persistent inconti-
nence are considered appropriate and preferable by UK clini-
cians. Potential options included for secondary surgery were:
repeat MUT insertion (same route as for primary surgery);
repeat MUT insertion (different route); abdominal
colposuspension; fascial sling surgery; urethral bulking
agents; and artificial urinary sphincter insertion. The survey
collected data about current practice preferences regarding
what options each respondent currently offered. Depending
on which options were offered, respondents were then pre-
sented with different comparisons in the form of the Surgical
Equipoise Scale (SES) [13]. In the SES, a choice of two op-
tions is presented, and the respondent is asked to indicate
whether one is preferred, bymarking on a ten-point scale, with
each option being Bstrongly preferred^ at either end of the
scale, and the midpoint of the scale representing Bno
preference^ (i.e. equipoise). The scale has been used to assess
the preferences of medical staff with regard to the treatment
alternatives in cancer surgery [14], and clinician views regard-
ing the role of urodynamic testing before surgery [15]. Results
are usually rendered as three number ratios of Bprefer option A
(to a greater or lesser extent)^: Bno preference^: Bprefer option
B (to a greater or lesser extent)^.
Clinician interviews
The survey included an invitation for clinicians to be
interviewed about their views and preferences in more detail.
All those who indicated an interest in being interviewed were
sent written information and asked to confirm their willing-
ness to participate. Purposive sampling was used to ensure
that clinicians with a range of the views expressed in the
SES were included. Telephone interviews using an interview
topic guide developed from discussions within the study team
were conducted by an experienced researcher (see acknowl-
edgements). Interviews were audio-recorded, transcribed and
anonymised before analysis. Analysis was based on the con-
stant comparative method [16] and facilitated by NVivo soft-
ware (QSR International, Australia). Transcripts were read in
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detail and open codes were initially applied to the data line by
line. These open codes were then incrementally grouped into
organising categories or themes. These categories were mod-
ified and checked constantly as further open codes were in-
corporated as analysis proceeded. The categories and their
specifications (the coding scheme) were then programmed
into the software. The coding scheme was used to process
the data set systematically by assigning each section of text
to a category, according to the category specifications.
Patient interviews
Eligible women were over 18 years old with a diagnosis of
recurrent/persistent stress incontinence who were due to have
repeat surgery, or had recently completed repeat surgery.
Exclusion criteria included previous continence surgery in
conjunctionwith prolapse surgery, an inability to providewrit-
ten informed consent, and an insufficient understanding of
English to participate in the interviews.
Clinicians from six study sites provided written infor-
mation about the study to all eligible women on their
clinic lists. Those willing to participate made contact
with the study team directly. Although we had planned
to sample purposively from respondents to ensure a
spread of women with immediate failed primary surgery
and later recurrence, and women who had different pri-
mary and secondary procedures, the lower than expected
recruitment meant that this was not feasible.
Written informed consent was obtained from each woman
and telephone interviews were conducted by the same re-
searcher who interviewed the clinicians (see acknowledge-
ments). The interviews were audio-recorded, transcribed and
anonymised before analysis. Interviews were informed by a
topic guide developed with input from our patient representa-
tive, and two pilot interviews were completed.
The interviews focused on women’s personal experi-
ences of failed primary surgery and decisions about sec-
ondary procedures, in addition to their views about any
future RCT in this area. To facilitate discussion of the
latter, the interviewer described the alternative surgical
and non-surgical options and explored women’s views
about the safety and acceptability of each, in terms of
likely cure rate, and taking into account complications,
length of hospital stay and likely recovery time. Of par-
ticular interest was exploring which alternative compari-
sons (e.g. a day case tape operation compared with an
inpatient operation with an abdominal incision) were
regarded as the most acceptable, and which were the most
likely comparisons to encourage (or discourage) patients
to take part in a research study comparing them. Data
analysis was based on the constant comparative method
[16], and facilitated by the use of NVivo software.
Statistical analysis
Survey data are presented as number (%) of respondents for
each question and response. Comparisons of responses by
clinical specialty were done using Chi-squared with Yates’
correction where appropriate. Significance was set at the 5%
level.
Results
Clinician survey
Two hundred and fifty-six survey replies were received, a
response rate of 38% overall. Forty respondents were subspe-
cialist urogynaecologists, 136 were gynaecologists with a
Bspecial interest^ in urogynaecology; 47 were subspecialist
urologists; and 33 urologists with a special interest in female
urology. Urogynaecology subspecialists complete a 3-year
formal training programme, and special interest clinicians
complete a shorter, formal training module, which covers pri-
mary procedures, but not apical compartment surgery.
Urology subspecialty and special interest is less formal. A
subspecialist is defined as someone with more than 50% of
clinical work in female urology; special interest urologists do
less than this.
Most of the respondents performed repeat continence sur-
gery themselves, but there were differences by specialty, with
a greater proportion of subspecialists operating themselves
(Table 1). When comparing treatments offered, there were
some differences between specialty groups (Fig. 1; Table 2).
Single-incision tapes were not offered by many respondents
(20 [7 .8%] Byes^ and 18 [7 .0%] Bsomet imes^) .
Urogynaecologists were more likely to offer pelvic floor mus-
cle exercises than urologists (p < 0.05), and also much more
likely to offer a repeat midurethral tape (MUT; p < 0.001).
Among those offering repeat MUT, there was a clear prefer-
ence for retropubic tape as second surgery in all cases, with
more urologists being willing to consider a transobturator tape
in either scenario (p < 0.05; Fig. 2; Table 3).
One hundred and fifty-two respondents completed the
Surgical Equipoise Scales (SES) [13] (28 subspecialist
urogynaecologists, 76 special interest gynaecologists, 36 sub-
specialist urologists and 12 special interest urologists. The
design of the survey meant that not all respondents had access
to every question. For all possible head to head comparisons,
it was noticeable that the Bno preference^ response (i.e. the
comparison was considered to be in equipoise) was almost
never the most common one. Only the special interest urolo-
gists, on two comparisons, were more likely to be in equi-
poise, and these numbers were small (colposuspension vs fas-
cial sling, and repeat MUT vs fascial sling). Second, there
were marked differences between specialties for several
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options (Table 4). For bladder neck injection vs pelvic floor
exercises, the special interest urogynaecologists were more in
favour of exercises. For both major procedure options vs ex-
ercises (colposuspension or fascial sling), and fascial sling vs
bladder neck injection, the urologists were more likely to fa-
vour the major surgery. In relation to major surgery, urologists
were more likely to be in favour of fascial sling surgery than
colposuspension.
There was some degree of consensus on a number of is-
sues. It was clear that for every SES presented with repeat
mid-urethral tape as an option, that this dominated every time
(last five rows of Table 4). It was noticeable that for repeat tape
vs colposuspension or fascial sling that urologists were more
likely to be in favour of the major surgery and were overall
more in equipoise about these two comparisons. Also, when
presented with an SES regarding how to deal with the existing
(failed) midurethral tape, there was a clear preference (78%)
for leaving this in position (remove tape 20: no preference 13:
leave tape 116) with no significant difference between speci-
alities (p = 0.167). Among the 40 respondents who offered
single-incision tapes, most preferred this to a colposuspension
(57.5%) and fascial sling (57.5%), with no difference between
specialities.
Clinician interviews
Twenty-one clinicians were interviewed: 2 general urologists,
5 urologists with a subspecialist interest, 7 subspecialist
urogynecologists and 7 urogynecologists with a special inter-
est. Discussion of current practice supported the variation ob-
served from the survey responses. Treatment preferences were
complex and influenced by a range of factors including: how/
why the first procedure had failed; time since the first
procedure; patient-related factors such as weight or other co-
morbidities; patient preferences for treatment; severity of the
incontinence; and the results of the urodynamics and other
investigations.
The overall preference for a repeat tape observed in the
survey was explained by both those who expressed this pref-
erence and those commenting on others’ practice as being
primarily due to this being a relatively easy and readily avail-
able option with which people were experienced and
comfortable:
[I do it] because it’s easy. I mean I’ve done a couple, just
sort of snipped out the middle bit of the tape that was
there…and put another one in, and so far they’ve done,
they’ve done well. (Participant S01)
My suspicion is that, you know, some people, rather
than referring them to somebody else who might be able
to offer these other options, they just get a repeat tape…
and of course a tape is a good operation, you know, it’s
got a good benefit risk profile, you know, it’s not very
interventional, and it’s got, and it’s got good successes.
(Participant S12)
The declining expertise in the more invasive procedures
was commonly discussed as an important factor underlying
the preference for repeat tapes:
There’s only [a] percentage of people who can do a
sling, and it’s quite a small one. And in fact increasingly
there will only be a small group that can do Burches
[colposuspensions], you know fluently and comfortably,
so I mean one of the problems is there are lots of
Table 1 Treatment patterns
among respondents Urogynaecology
subspecialist
Urogynaecology
special interest
Urology
subspecialist
Urology
special
interest
p*
Replies n = 40 n = 136 n = 47 n = 33
Operate myself 36 (90) 87 (64.0) 43 (91.5) 14 (42.4)
Refer to another colleague
locally
2 (5) 14 (10.3) 1 (2.1) 10 (30.3)
Refer to a colleague in a
secondary level centre
0 3 (2.2) 1 (2.1) 1 (3.0) <0.001
Refer to a colleague in a
tertiary level centre
0 20 (14.7) 1 (2.1) 4 (12.1)
Other responsea 2 (5) 12 (8.8) 1 (2.1) 4 (12.1)
Data are number (%)
*Chi-squared with Yates’ correction for entire table
a Examples of text responses included: B…depending on clinical scenario I operate myself or refer to colleague
locally…^; Bdepends on what is decided at multidisciplinary meeting. If pretty much continent, and we are
considering bulking agents, I do it. If we think she would benefit from repeat MUT or a fascial sling or other
complications, we refer to the tertiary unit^; BDiscuss atMDTand operate with colleague^; BI operate jointly with
a urogynaecologist on a regular basis and also often with another urologist, both within our own urodynamic
MDT structure.^
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surgeons who have very limited repertoires and so that
limits them to what they can do. (Participant S06)
As regards a future RCT, there was general agreement that
this is an important research topic, as evidence is needed; only
one of the participants would not be willing to be recruited to
it. However, views differed on what would be appropriate
comparisons in an RCT and how this could best be designed.
Different views were expressed about the acceptability of dif-
ferent procedures to include, the acceptability of including
minimally invasive or non-surgical options (such as bulking
agents or pelvic floor exercises) alongside surgical ones, and
the number of trial arms that would be needed. Half of those
who were willing to be recruited in principle (10 out of 20)
made it clear that this would depend on the treatment options
included (but there was no consensus among them on these),
and sometimes their lack of experience or confidence with
certain procedures would rule them out completely.
Patient interviews
Eleven women were recruited and interviewed across three
study sites. Of these, 5 had recently had their secondary pro-
cedure and the other 6 were awaiting theirs; secondary proce-
dures included colposuspension, TVT, TOT, and bulking in-
jections. All but 2 women reported having considered more
than one possible procedure and discussing this with both
clinical staff and family members. The 2 who did not, said
that they were happy to take their clinician’s recommendation
without further discussion.
Ultimately though, those who said they looked at more
than one possible procedure felt that their options were limited
Fig. 1 Bars indicate percentage
response. For actual numbers see
Table 2
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given either their past treatment experiences and/or their per-
sonal preferences, such as avoiding a general anaesthetic or a
long recovery period:
I didn’t want a lengthy stay, and I didn’t want to go
through, all that was at the back of my mind is that if I
have that operation again, I might, the wound may not
heal like it should…[but]… the main reason why I
didn’t want surgery again is because I had a respiratory
arrest…that’s why I was glad when the consultant said
there’s another thing that he could do. (Participant 03)
Because of these apparent restrictions, most women who
reported looking at options talked about their decision-making
as being akin to a process of elimination rather than as a more
positive process of selection between possible options:
I felt as though everything else had failed…and, you
know, I thought well, I’ll try this [colposuspension] I
didn’t know what to try next really […] I sort of jumped
at it, you know, wholeheartedly, think Booh, is it going
to work? Hopefully it will^. (Participant 05)
Most women were not prepared to consider repeating pro-
cedures they had previously undergone, as they regarded these
as being failures. The only exception to this was a womanwho
had undergone a successful colposuspension 20 years ago that
had now failed—she was keen to repeat this procedure, as it
had been effective for so long with no complications. The
distinction between immediate and longer-term failure and
the assumption of repeated success are clearly important:
I just wanted something that I knewwas going to work. I
never considered it [another option], I just wanted some-
thing, because I’d had it done before…I knew it was
going to last me for the rest of my life. (Participant 08)
Given these preferences about the procedures they did and
did not regard as acceptable, it is not surprising that most
women did not think randomisation in a future RCT would
be acceptable. This was most often framed in terms of them
not wanting to be randomised to repeat a procedure that had
already failed for them, but factors such as wanting to avoid a
general anaesthetic were also mentioned:
Well, like you say, you don’t know what, if it’s just a
random treatment, you don’t knowwhat you’re going to
end up with, do you? If they’d have said, you know, if
they’d said Byou’ve got to have another TVT ,^ I
wouldn’t have wanted it. (Participant 01)
Although women were generally not prepared to enter a
trial where there was a chance that they could be randomised
to a treatment that they had already tried, of the pairings put to
Table 2 Summary of treatments offered by specialty
BWould you offer…for recurrent or
persistent incontinence?^
Urogynaecology
subspecialist
Urogynaecology special
interest
Urology
subspecialist
Urology special
interest
p*
Pelvic floor muscle exercise Yes
Sometimes
No
Total
21 (58.3)
8 (22.3)
7 (19.4)
36
52 (63.4)
26 (31.7)
4 (4.9)
82
13 (31.7)
20 (48.8)
8 (19.5)
41
6 (42.8)
4 (28.6)
4 (28.6)
14
<0.05
Bladder neck injection Yes
Sometimes
No
Total
16 (48.5)
14 (42.4)
3 (9.1)
33
31 (41.3)
29 (38.7)
15 (20.0)
75
15 (39.5)
19 (50.0)
4 (10.5)
38
4 (30.8)
5 (38.4)
4 (30.8)
13
ns
Single-incision tape Yes
Sometimes
No
Total
4 (12.9)
4 (12.9)
23 (74.2)
31
11 (15.3)
8 (11.1)
53 (73.6)
72
2 (5.6)
4 (11.2)
30 (83.2)
36
3 (25.0)
2 (16.7)
7 (58.3)
12
ns
Burch colposuspension Yes
Sometimes
No
Total
15 (48.4)
11 (35.5)
5(16.1)
31
25 (34.7)
33 (45.8)
14 (19.5)
72
18 (50.0)
16 (44.4)
2 (5.6)
36
8 (66.7)
3 (25.0)
1 (8.3)
12
ns
Repeat midurethral tape (any
type)
Yes
Sometimes
No
Total
22 (71.0)
5 (16.1)
4 (12.9)
31
55 (76.4)
16 (22.2)
1 9 (1.4)
72
8 (22.2)
16 (44.5)
12 (33.3)
36
5 (35.7)
4 (28.6)
5 (35.7)
14
<0.001
Data are number of respondents (%); the number of individual replies varied between questions. See Fig. 1 for proportion of responses with speciality
differences
ns not significant
*Chi-squared with Yates’ correction
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them for consideration, randomisation between two larger sur-
gical procedures was the most acceptable. This is probably not
surprising given that most had tried less invasive treatments
first.
Discussion
The issue of how to manage recurrent or persistent stress in-
continence after the failure of primary surgery is clearly an
important and yet contentious topic. Our research has
highlighted this, and explored the key issues of importance
to clinicians, and most importantly, to women. From a sur-
geon’s perspective, the survey data clearly demonstrate that
the lack of evidence means that current practice is highly
variable across the UK, based on personal preference or
experience. Most had strong views in favour of one option
for almost every comparison we presented, illustrating a lack
of equipoise, but in the face of an acknowledged lack of re-
search data to support or inform their position. There were
some trends observed, with urologists being more likely to
favour major interventions over more minor procedures,
whereas gynaecologists had a tendency to prefer less major
alternatives such as pelvic floor muscle training or bladder
neck injections.
What was most striking was the dominant effect of re-
peat MUT in every comparison in which it was included, a
finding that was confirmed from the interviews as being a
consequence of training and experience rather than an ac-
tual preference. It appeared that many respondents were
unable to offer alternative procedures because they had
no t r e c e i v e d t r a i n i n g i n p r o c e du r e s s u c h a s
Fig. 2 Bars indicate percentage
response. For actual numbers see
Table 3. TVT tension-free vaginal
tape, TOT transobturator tape
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colposuspension or fascial sling. This is an important find-
ing not only for future research plans, but also as a training
and clinical governance issue, bearing in mind the increas-
ing concerns about MUT complications, how they are
managed, and the possibility of providing women with
alternative choices [17, 18].
From the patients’ perspective, the variability and inconsis-
tency of surgeons’ responses in general is a finding that will
Table 4 Responses to different
options presented in the Surgical
Equipoise Scale
BA^ vs BB^ Urogynaecology
subspecialist
(n = 28)
Urogynaecology
special interest
(n = 76)
Urology
subspecialist
(n = 36)
Urology
special
interest
(n = 12)
p*
BNI vs PFE 10: 7: 11 22: 6: 48 18: 7: 7 4: 2: 3 <0.02
Fascial sling vs PFE 14: 4: 10 23: 12: 41 25: 4: 3 9: 0: 0 <0.001
PFE vs SIS 15: 3: 9 34: 10: 27 18: 7: 5 2: 3: 4 ns
Colposuspension vs
PFE
20: 2: 5 36: 3: 32 21: 5: 4 9: 0: 0 <0.02
Fascial sling vs BNI 18: 2: 8 18: 10: 29 24: 4: 4 6: 1: 2 <0.01
Colposuspension vs
BNI
21: 1: 6 26: 10: 21 21: 4: 7 6: 1: 2 ns
BNI vs SIS 13: 10: 5 31: 14: 12 20: 10: 2 4: 3: 1 ns
Colposuspension vs
fascial sling
13: 6: 7 40: 11: 7 8: 10: 16 3: 6: 2 <0.01
Repeat MUT vs
PFE
21: 4: 2 48: 7: 16 16: 5: 3 9: 0: 0 ns
Repeat MUT vs
BNI
19: 5: 3 47: 12: 12 16: 4: 4 6: 1: 2 ns
Repeat MUT vs SIS 23: 2: 2 59: 6: 5 23: 1: 0 7: 2: 0 ns
Repeat MUT vs
colposuspension
17: 7: 3 45: 17: 8 10: 7: 7 2: 3: 4 ns
Repeat MUT vs
fascial sling
15: 8: 4 52: 15: 3 6: 6: 12 2: 4: 3 <0.001
Responses are presented as number of replies, laid out as: prefer option A: no preference: prefer option B. For all
comparisons, BA^ is the first option and BB^ the second option given in the first column
BNI bladder neck injection, PFE pelvic floor exercises, SIS single-incision tape, MUT mid-urethral tape, ns not
significant
*Chi-squared with Yates’ correction comparing equipoise responses across the four specialty groupings
Table 3 Questions relating only
to repeat midurethral tape option Urogynaecology
subspecialist
Urogynaecology
special interest
Urology
subspecialist
Urology
special
interest
p*
n = 27 n = 72 n = 24 n = 10
Where the primary tape was retropubic…
I would only offer
repeat retropubic
17 (63.0) 32 (44.4) 3 (12.5) 2 (20.0)
I would only offer
transobturator
2 (7.4) 9 (12.5) 4 (16.7) 3 (30.0) <0.05
I would offer both 8 (29.6) 31 (43.1) 17 (70.8) 4 (40.0)
Where the primary tape was transobturator…
I would only offer a
retropubic
24 (88.9) 55 (76.4) 12 (100) 6 (60.0)
I would only offer
repeat transobturator
2 (7.4) 2 (2.8) 0 1 (10.0) <0.05
I would offer both 1 (3.7) 14 (19.4) 12 3 (30.0)
Data are number of respondents (%); the number of individual replies varied between questions. See Fig. 2 for
proportion responses of responses with specialty differences
ns not significant
*Chi-squared with Yates’ correction
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generate considerable concern, particularly given that this sur-
vey was only sent to those with specific training and a de-
clared interest in pelvic floor dysfunction. Patients hope and
expect that doctors know what they are talking about and that
treatments offered are the most suitable/effective. However, it
is clear from the data that the treatments women may be of-
fered may depend largely upon the discipline and training of
the surgeon, and that the choice of treatments offered depends
upon the surgeon’s skills, experience and opinion rather than
any evidence. This highlights the importance of comprehen-
sive and appropriate training, in addition to the need for re-
search addressing the specific issue of failed continence sur-
gery, to avoid and reduce the variability in patient choice that
is currently present and to provide greater consistency of care
provision. The patient interviews demonstrated that women
often had firm opinions about what options they would con-
sider for future care. These opinions were usually based on
eliminating unacceptable options, usually including a repeat
of the failed original procedure. Given that most women cur-
rently will have received anMUTas primary surgery, this runs
contrary to the views of most surgeons, who preferred a repeat
MUT above all other options.
From the perspective of designing future research, this
study has highlighted several issues. Firstly, and importantly,
it is clear that more research is needed to address these uncer-
tainties, a fact that was acknowledged by both the patients and
clinicians who participated. Second, there are important issues
of research design to consider: for patients, surgical options
represent different demands upon them. These range from
choosing between day-case versus inpatient surgery, short or
longer term recovery from surgery, and different combinations
and risks of potential side effects. We have demonstrated that
patients feel strongly about avoiding a repeatMUT procedure,
especially if they have suffered complications (e.g. erosion
into the vagina, leading to the need for excision and hence
recurrent incontinence), and many have reservations about
the acceptability of randomisation as a concept in this scenar-
io. These issues are vital to consider during the design of any
future research, to provide a study design that is acceptable to
women, in which they are willing to take part, and that ad-
dresses questions of direct relevance to them, and other wom-
en in the future. It was unfortunate that we were not able to
recruit more women who had experienced failure of their pri-
mary surgery for interview. As far as we are able to ascertain,
this was because there were fewer eligible women than antic-
ipated across the study sites. However, although we were only
able to recruit 11 women for interview, these were a diverse
group with a range of experiences and preferences. Therefore,
while we cannot be sure that we reached saturation with this
number of interviews, this does not undermine the usefulness
of the data collected.
It was clear from interviews with clinicians that a question-
naire providing treatment alternatives did not capture some of
the complexity of planning appropriate treatment for women
after failed surgery and we acknowledge this. Interviewees
discussed how patient-specific factors such as obesity, co-
morbidity, urethral mobility, and voiding dysfunction would
need to be considered, in addition to any preferences
expressed by the patient. These factors also need to be ad-
dressed in the design of any future study, as a means of com-
prehensively assessing, and potentially stratifying, allocation
to different treatment options. Any planned trial would cer-
tainly require multicentre recruitment and thusmust be accept-
able and meaningful to most of the consultant gynaecologists
and urologists in the UK and beyond. Acceptability includes
factors such as which alternative procedures should be com-
pared; whether the degree of vaginal scarring and urethral
mobility should be taken into account; and what diagnostic
tests are required before surgery.
The response rate to the survey was relatively low at 38%,
which some may argue reduces the generalisability of the
results. We sent two reminders. It is possible that the non-
responders were not actively treating women with recurrent
incontinence, as the members work across a range of hospital
settings within the UK, but we cannot be certain. Despite the
low proportion of responses, we believe that the message from
the data is clear and do not think that practice would be much
different among non-responders.
In conclusion, this study reveals the complexity and diffi-
culty of decision-making for women with recurrent stress in-
continence.Women’s preferences are limited by personal pref-
erences, chiefly a wish to avoid a repeat a previously unsuc-
cessful procedure. There is no consensus among surgeons and
it is clear for a variety of reasons that most prefer to offer a
repeat MUT; thus, there is clear mismatch of expectation,
given that MUT is the most common primary continence pro-
cedure worldwide. Future comparative studies are needed to
provide evidence to support decision-making, but because of
perceived differences in treatments available, randomisation
to any future trial was unacceptable to most women, except
between two major procedures. Furthermore, not all clinicians
are able to offer all possible options.
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